Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 49

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Synthesis and characterization of silver nanoparticles and their promising antimicrobial effects

Iwuji, Chika, Saha, Hritaal, Ghann, William, Dotson, Dominique, Bhuiya, Md. Anwarul Kabir, Parvez, Md. Shahnawaz, Jahangir, ZMG Sarwar, Rahman, Mohammed Muzibur, Chowdhury, Faisal Islam, Uddin, Jamal · 2024 · Chemical Physics Impact

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chphi.2024.100758

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 64

  1. Roco, 2003, Nanotechnology: convergence with modern biology and medicine, Curr. Opin. Biotechnol., 14, 337, 10.1016/S0958-1669(03)00068-5 · DOI · Paper page
  2. Duncan, 2005, Nanomedicine gets clinical, Mater. Today, 8, 16, 10.1016/S1369-7021(05)71032-4 · DOI
  3. He, 2021, Nanoscale covalent organic frameworks: from controlled synthesis to cancer therapy, Chem. Commun., 57, 12417, 10.1039/D1CC04846E · DOI · Paper page
  4. Luo, 2021, Size controlled fabrication of enzyme encapsulated amorphous calcium phosphate nanoparticle and its intracellular biosensing application, Colloids Surf. B, 201, 10.1016/j.colsurfb.2021.111638 · DOI
  5. Veisi, 2023, Supported gold nanoparticles on lignosulfonate coated magnetic nanoparticles: investigation of its catalytic efficiency in the reductive formylation of nitroarenes, Inorg. Chem. Commun., 154, 10.1016/j.inoche.2023.110897 · DOI
  6. Rai, 2009, Silver nanoparticles as a new generation of antimicrobials, Biotechnol. Adv., 27, 76, 10.1016/j.biotechadv.2008.09.002 · DOI · Paper page
  7. Rizzello, 2014, Nanosilver-based antibacterial drugs and devices: mechanisms, methodological drawbacks, and guidelines, Chem. Soc. Rev., 43, 1501, 10.1039/C3CS60218D · DOI · Paper page
  8. Chaloupka, 2010, Nanosilver as a new generation of nanoproduct in biomedical applications, Trends Biotechnol., 28, 580, 10.1016/j.tibtech.2010.07.006 · DOI · Paper page
  9. Alexander, 2009, History of the medical use of silver, Surg. Infect., 10, 289, 10.1089/sur.2008.9941 · DOI · Paper page
  10. Klasen, 2000, Historical review of the use of silver in the treatment of burns. I. Early uses, Burns, 26, 117, 10.1016/S0305-4179(99)00108-4 · DOI · Paper page
  11. Klasen, 2000, Historical review of the use of silver in the treatment of burns. II. Renewed interest for silver, Burns, 26, 131, 10.1016/S0305-4179(99)00116-3 · DOI · Paper page
  12. Atiyeh, 2007, Effect of silver on burn wound infection control and healing: review of the literature, Burns, 33, 139, 10.1016/j.burns.2006.06.010 · DOI · Paper page
  13. Silvestry-Rodriguez, 2007, Silver as a disinfectant, Rev. Environ. Contam. Toxicol., 191, 23
  14. Morones, 2005, The bactericidal effect of silver nanoparticles, Nanotechnology, 16, 2346, 10.1088/0957-4484/16/10/059 · DOI · Paper page
  15. Chen, 2008, Nanosilver: a nanoproduct in medical application, Toxicol. Lett., 176, 1, 10.1016/j.toxlet.2007.10.004 · DOI · Paper page
  16. Iravani, 2014, Synthesis of silver nanoparticles: chemical, physical and biological methods, Res. Pharm. Sci., 9, 385
  17. Klaus, 1999, Silver-based crystalline nanoparticles, microbially fabricated, Proc. Natl. Acad. Sci. U. S. A., 96, 13611, 10.1073/pnas.96.24.13611 · DOI · Paper page
  18. Lee, 2010, Bioimaging of targeted delivery of nanoparticles using renilla luciferase-Luc8, Nat. Photonics, 4, 222
  19. Baran, 2023, Green synthesis of silver nanoparticles from Allium cepa L. Peel extract, their antioxidant, antipathogenic, and anticholinesterase activity, Molecules, 28, 2310, 10.3390/molecules28052310 · DOI
  20. Baran, 2021, Ecofriendly/rapid synthesis of silver nanoparticles using extract of waste parts of artichoke (Cynara scolymus L.) and evaluation of their cytotoxic and antibacterial activities, J. Nanomater., 1
  21. Pal, 2007, Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli, Appl. Environ. Microbiol., 73, 1712, 10.1128/AEM.02218-06 · DOI · Paper page
  22. Shrivastava, 2007, Characterization of enhanced antibacterial effects of novel silver nanoparticles, Nanotechnology, 18, 10.1088/0957-4484/18/22/225103 · DOI · Paper page
  23. Sondi, 2004, Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for gram-negative bacteria, J. Colloid Interface Sci., 275, 177, 10.1016/j.jcis.2004.02.012 · DOI · Paper page
  24. Martinez-Castanon, 2008, Synthesis and antibacterial activity of silver nanoparticles with different sizes, J. Nanopart. Res., 10, 1343, 10.1007/s11051-008-9428-6 · DOI · Paper page
  25. Lok, 2007, Silver nanoparticles: partial oxidation and antibacterial activities, J. Biol. Inorg. Chem., 12, 527, 10.1007/s00775-007-0208-z · DOI · Paper page
  26. Weiner-Lastinger, 2022, The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network, Infect. Control Hosp. Epidemiol., 43, 12, 10.1017/ice.2021.362 · doi:10.1017/ice.2021.362
  27. Li, 2009, Efflux-mediated drug resistance in bacteria, Drugs, 69, 1555, 10.2165/11317030-000000000-00000 · DOI · Paper page
  28. Ventola, 2015, The antibiotic resistance crisis: part 1: causes and threats, Pharm. Ther., 40, 277
  29. Fair, 2014, Antibiotics and bacterial resistance in the 21st century, Perspect. Med. Chem., 6, 25
  30. Pal, 2016, The structure and diversity of human, animal, and environmental resistomes, Microbiome, 4, 54, 10.1186/s40168-016-0199-5 · DOI · Paper page
  31. Wu, 2023, Self-assembly multifunctional DNA tetrahedron for efficient elimination of antibiotic-resistant bacteria, Adv. Genom. Tech., 5, 1
  32. Ou, 2024, Covalently grafting polycation to bacterial cellulose for antibacterial and anti-cell adhesive wound dressings, Int. J. Biol. Macromol., 269
  33. Yuan, 2023, Biomimetic peptide dynamic hydrogel inspired by humanized defensin nanonets as the wound-healing gel coating, Chem. Eng. J., 470, 10.1016/j.cej.2023.144266 · DOI
  34. Zhang, 2022, Ten-gram-scale mechanochemical synthesis of ternary lanthanum coordination polymers for antibacterial and antitumor activities, Front. Chem., 10
  35. Harris, 2002, An introduction to staphylococcus aureus, and techniques for identifying and quantifying S. aureus Adhesins in relation to adhesion to biomaterials: review, Eur. Cell. Mater., 4, 39, 10.22203/eCM.v004a04 · DOI · Paper page
  36. Lowy, 1998, Staphylococcus aureus infections, N. Engl. J. Med., 339, 520, 10.1056/NEJM199808203390806 · DOI · Paper page
  37. Lyczak, 2000, Establishment of pseudomonas aeruginosa infection: lessons from a versatile opportunist, Microbes Infect., 2, 1051, 10.1016/S1286-4579(00)01259-4 · DOI · Paper page
  38. Nataro, 1998, Diarrheagenic Escherichia coli, Clin. Microbiol. Rev., 11, 142, 10.1128/CMR.11.1.142 · DOI · Paper page
  39. Miller, 2024, ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics, Nat. Rev. Microbiol., 10.1038/s41579-024-01054-w · DOI · Paper page
  40. Rai, 2012, Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria, J. Appl. Microbiol., 112, 841, 10.1111/j.1365-2672.2012.05253.x · DOI · Paper page
  41. Franci, 2015, Silver nanoparticles as potential antibacterial agents, Molecules, 20, 8856, 10.3390/molecules20058856 · DOI · Paper page
  42. Ahmed, 2016, A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: a green expertise, J. Adv. Res., 7, 17, 10.1016/j.jare.2015.02.007 · DOI · Paper page
  43. Iravani, 2014, Synthesis of silver nanoparticles: chemical, physical and biological methods, Res. Pharm. Sci, 9, 385
  44. Turkevich, 1951, A study of the nucleation and growth processes in the synthesis of colloidal gold, Discuss. Faraday Soc., 11, 55, 10.1039/df9511100055 · DOI · Paper page
  45. Lee, 2019, Silver nanoparticles: synthesis and application for nanomedicine, Int. J. Mol. Sci., 20, 865, 10.3390/ijms20040865 · DOI · Paper page
  46. Chen, 2008, Nanosilver: a nanoproduct in medical application, Toxicol. Lett., 176, 1, 10.1016/j.toxlet.2007.10.004 · DOI · Paper page
  47. Rai, 2009, Silver nanoparticles as a new generation of antimicrobials, Biotechnol. Adv., 27, 76, 10.1016/j.biotechadv.2008.09.002 · DOI · Paper page
  48. Durán, 2007, Antibacterial effect of silver nanoparticles produced by fungal process on textile fabrics and their antimicrobial efficiency evaluation, J. Biomed. Nanotechnol., 3, 203, 10.1166/jbn.2007.022 · DOI · Paper page
  49. Zhang, 2016, Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches, Int. J. Mol. Sci., 17, 1534, 10.3390/ijms17091534 · DOI · Paper page
  50. Chaloupka, 2010, Nanosilver as a new generation of nanoproduct in biomedical applications, Trends Biotechnol., 28, 580, 10.1016/j.tibtech.2010.07.006 · DOI · Paper page
  51. Zhao, 2021, Facile synthesis of silver nanoparticles modified with chitosan for non-enzymatic hydrogen peroxide sensing, Microchim. Acta, 188, 267
  52. Ahmadi, 2020, Rapid and facile synthesis of silver nanoparticles using recombinant silk protein for antimicrobial applications, Nanoscale Res. Lett., 15, 102
  53. Li, 2021, Facile green synthesis of silver nanoparticles using Lonicera japonica flower extract for antibacterial and catalytic activities, J. Nanopart. Res., 23, 168
  54. Nune, 2009, Green nanotechnology from tea: phytochemicals in tea as building blocks for production of biocompatible gold nanoparticles, J. Mater. Chem., 19, 2912, 10.1039/b822015h · DOI · Paper page
  55. Naraginti, 2017, Green synthesis of silver nanoparticles using an aqueous extract of Salvia hispanica (Chia) seeds with its potential antibacterial activity, J. Mol. Liq., 224, 304
  56. Bar, 2009, Green synthesis of silver nanoparticles using latex of Jatropha curcas, Colloids Surf. A Physicochem. Eng. Asp., 339, 134, 10.1016/j.colsurfa.2009.02.008 · DOI · Paper page
  57. Marambio-Jones, 2010, A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment, J. Nanopart. Res., 12, 1531, 10.1007/s11051-010-9900-y · DOI · Paper page
  58. Prabhu, 2012, Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects, Int. Nano Lett., 2, 32, 10.1186/2228-5326-2-32 · DOI · Paper page
  59. Sondi, 2004, Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria, J. Colloid Interface Sci., 275, 177, 10.1016/j.jcis.2004.02.012 · DOI · Paper page
  60. Durán, 2016, Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity, Nanoscale Res. Lett., 11, 1
  61. Kumar, 2021, Mechanistic insights into antibacterial action of metal nanoparticles, Front. Microbiol., 12
  62. Li, 2010, Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli, Appl. Microbiol. Biotechnol., 85, 1115, 10.1007/s00253-009-2159-5 · DOI · Paper page
  63. Jo, 2009, Direct accumulation of silver from silver nanoparticles into edible plants, J. Am. Chem. Soc., 131, 11652
  64. Rai, 2012, Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria, J. Appl. Microbiol., 112, 841, 10.1111/j.1365-2672.2012.05253.x · DOI · Paper page

Cited by

Metadata

Authors
Iwuji, C., Saha, H., Ghann, W., Dotson, D., Bhuiya, M. A. K., Parvez, M. S., Jahangir, Z. S., Rahman, M. M., Chowdhury, F. I., & Uddin, J.
Venue
Chemical Physics Impact
Publisher
Elsevier BV
Published
2024-12
Volume
9
Pages
100758
ISSN
2667-0224
Cited by
49
References
3
Language
en
Licence
Funders
U.S. Department of Education

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.